Compare Globus Medical Inc. Class A Common Stock (GMED) vs Marathon Petroleum Corp (MPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Marathon Petroleum Corp — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.85 (market cap $10.25B), while Marathon Petroleum Corp trades at $484.14 (market cap $136.18B). The key difference: Marathon Petroleum Corp is far larger — about 13.3× Globus Medical Inc. Class A Common Stock's market cap, and Marathon Petroleum Corp pays a 0.82% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Marathon Petroleum Corp for 53 Days on average.
| GMED | MPC | |
|---|---|---|
Market Cap | $10.25B | $136.18B |
Volume | 1,059,528 | 1,631,475 |
Sector | Health | Energy |
52-Week High | $96.82 | $484.92 |
52-Week Low | $58.33 | $162.63 |
Typical Hold Time | 0 Days | 53 Days |
Enterprise Value | $9.76B | $162.70B |
Dividend Yield | — | 0.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Marathon Petroleum (MPC) trades at $476.98, up 3.96% today, with a bullish technical outlook and strong earnings beats in recent quarters. The stock shows robust profitability with a 47.9% ROE and trades at a P/E of 16.81, below the sector average. Recent news highlights refining margin strength and positive analyst sentiment, though risks include potential diesel export policies and volatile energy markets.
MPC presents a compelling investment case with solid fundamentals, earnings momentum, and a unanimous buy rating from analysts. However, investors face risks from regulatory uncertainty and cyclical energy demand. The stock's current price near resistance at $479 requires monitoring for breakout or pullback opportunities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Marathon Petroleum Corp
Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →
